Related Experiment Video

Updated: Apr 18, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.7K

Neonatal haemostasis and the management of neonatal thrombosis

Andrew Will1

  • 1Department of Paediatric Haematology, Royal Manchester Children's Hospital, Manchester, UK.

British Journal of Haematology
|January 20, 2015
PubMed

Insights

Neonatal thrombosis management requires individualized assessment due to weak evidence. Understanding unique neonatal coagulation physiology is key for effective antithrombotic therapy, monitoring, and dosing strategies.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Thrombosis

Background:

  • Previous reviews in 2012 provided similar guidance on neonatal antithrombotic therapy.
  • Evidence supporting current recommendations for neonatal thrombosis treatment remains limited.
  • Therapeutic decisions necessitate a careful balance of risk versus benefit for each neonate.

Purpose of the Study:

  • To review the unique coagulation physiology in neonates.
  • To explain how neonatal physiology impacts antithrombotic therapy.
  • To guide physicians on monitoring, dosing, and therapeutic strategies for neonatal thrombosis.

Main Methods:

  • Literature review of neonatal coagulation and thrombosis management.
  • Analysis of existing guidelines and evidence.
  • Synthesis of physiological factors influencing treatment.

Main Results:

  • Neonatal coagulation differs significantly from adult physiology.
  • These differences necessitate tailored approaches to antithrombotic therapy.
  • Current evidence base for treatment recommendations is weak.

Conclusions:

  • Understanding neonatal coagulation is crucial for effective thrombosis management.
  • Individualized risk-benefit assessment is paramount in treating neonatal thrombosis.
  • Further research is needed to strengthen evidence for antithrombotic therapies in neonates.

Keywords:
heparinneonatal thrombosisrecombinant tissue plasminogen activatorthrombolysisthrombophilia

More Related Videos

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well06:59

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

143
Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats07:56

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats

Published on: April 21, 2017

11.2K

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
400
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
475
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
19.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
16.2K